Home/Investors/U.S. Department of Defense

U.S. Department of Defense

Biotech Investor · 4 portfolio companies

Portfolio

4

Focus Areas

8

Top Stage

Commercial

Investment Focus

Hematology Infectious Disease Sepsis Septic Shock Critical Care Trauma Neurology Oncology

Portfolio Companies

Company	Stage	Valuation	Focus
Entegrion	Commercial	—	Hematology
ANP Technologies	Commercial	—	Infectious Disease
Vivacelle Bio	Phase 3	—	Sepsis, Septic Shock
Rio Pharmaceuticals	Phase 2	—	Neurology, Oncology

Frequent Co-Investors

National Institutes of Health1 shared Venture Capital Firms (unspecified)1 shared Department of Homeland Security1 shared Venture Capital1 shared Alzheimer's Disease Discovery Foundation (AADF)1 shared National Institutes of Health (National Institute on Aging)1 shared